Background: Egypt faces a dispropotionately higher Breast Cancer (BC) mortality rate , reflected in an elevated mortality-to-incidence ratio. BC accounts for 36% of new cancer cases and 23% of cancer-related deaths in Egyptian women.In response Egypt launched the Presidential initiative for Women's health ( PIWH) in 2019, a nationwide screening and care program aiming to reduce advanced-stage presentation and 40% reduction in BC mortality by2040.
Objectives: The program seeks to redduce mortality through early detection,timly diagnosis, and access to comprehensive treatment. The PIWH focused on achiving universal access to high-quality, Guideline-based treatment regardless of socio-economic status; strengthening surivial and reduce health care burden and minimaizing the economic impact of BC through cost-effective prevention and early detection.
Methods :
The PIWH implemented a national inclusive, and free BC screening program targeting all women aged 18 years and aboive, using the Malysian BC control and prevention program as example. Clinical breast examination (CBE) was adopted as the primary screening modality. screening begins at primary healthcare facilities or mobile units (extend screening and diagnostic services to rural and remote areas) where women receive BC awareness education and undergo CBE preformed by trained healthcare professionals. those with abnormal examinations are referred through a structured pathway to tertiary healthcare (THC) units for further duagnostic evaluation, including ultrasound , mammography and biopsy when indicated. Treatment decisions for women diagnosed with BC are made by multidisciplinary teams (MDT) at THC. A coordinated collaboration between government , private sector, and national non goernmental organizations supports outreach, awareness, diagnostics and referral. Accurate and timely diagnosis was strenthened through decentralization and upgrading of pathology sevices nationwide, enabled Public-private partnerships. This included expansion of digital pathology , integration of AI to support imaging interpretation and workflow efficiency. Mammography capacity was scaled up as well.
Results : Implementation of PIWH led to substantial improvements across the BC care continuum. The average time from first presentation to diagnosis was reduced from 180-280 days to 49, while diagnostic turnaround time decresed from 30 to 10 days. Time from diagnosis to treatment initiation declined from 180-280 to 30-38 days.  PIWH included novel targted therapy in early and metastatic stages treatment, surgical practice shifted toward breast-conservative and oncoplastic approaches with an associated increase in pathological complete response rate to approximately 70%. 
The initiative exceeded all WHO GBCI KPIs : 80.5% of BC are now diagnosed at stage 0-II and 100% of patients receive MDT guided treatment. More than 30000 healthcare providers were trained, national BC guidlines were established and MDTs became mandatory. since 2019 , over 22 million women were screened with advanced diagnostics provided to over 823000 women. Early stage diagnosis increased to 65% generating an estimated savings of 127 mil USD with a 57.4% return on investment.
conclusion: PIWH transformed BC screening, diagnosis, and treament in Egypt delivering measurable improvments in timeliness, equity and quality of care exceeding the WHO GBCI targets. Economic analyses demonstrate significant cost saving alongside improved clinical outcomes. PIWH provides a scalable model for comprehensive BC control in LMICS.